Giuseppe Remuzzi
ItalyscientistMale9.0Global Dominance: 0.00%Giuseppe Remuzzi is the director of the Mario Negri Institute for Pharmacological Research in Italy and a renowned nephrologist. He has gained recognition for his research in kidney diseases and the role of various dietary practices on health outcomes. Recently, he was in the news for his commentary on an American study that challenges the health benefits of intermittent fasting, particularly the '16:8' method, suggesting it may increase cardiovascular risks rather than promote longevity.
Country presence
Recent news mentions
Giuseppe Remuzzi wrote clearly on the role of vaccines, providing important and unequivocal scientific data.
Opinioni | Covid, chiudere le polemiche: parla la scienzaItaly· 2026-07-25Professor Giuseppe Remuzzi commented on the predictive capabilities of AI regarding suicidal intentions.
ChatGpt «sapeva» della strage in Canada mesi prima che avvenisse ma OpenAI decise di non avvisare le autoritàItaly· 2026-02-21
Giuseppe Remuzzi is the director of the Mario Negri Institute and spoke about the role of artificial intelligence in medicine.
Remuzzi: «L'intelligenza artificiale fa diagnosi quattro volte più corrette dei medici. Ogni anno 2,6 milioni di morti a causa di valutazioni sbagliate: facciamoci aiutare dall'AI»Italy· 2026-01-25
Giuseppe Remuzzi explained that there has never been a correlation between paracetamol use during pregnancy and autism.
Leucovorin, la «pillola contro l'autismo» presentata dall'amministrazione Trump funziona o no?Italy· 2025-09-23
Giuseppe Remuzzi is the director of the Mario Negri Institute and comments on the safety of paracetamol during pregnancy.
Autismo e paracetamolo in gravidanza, Remuzzi: «Nessun aumento del rischio, rimane il farmaco più sicuro»Italy· 2025-09-23
Professor Giuseppe Remuzzi expresses concern over the consequences of funding cuts on pandemic preparedness.
Remuzzi: «I tagli di Kennedy Jr ai vaccini? Una mossa che può impedirci di affrontare future pandemie»Italy· 2025-08-09
Giuseppe Remuzzi is the director of the Mario Negri Institute for Pharmacological Research and a professor of Nephrology at the University of Milan.
Il digiuno intermittente può nuocere alla salute: lo studio americano. Remuzzi: «Effetti a breve termine positivi. E poi?»Italy· 2025-02-17